CLINICAL_TRIALS
research
· 2024-07-01
Clinical Trial Update: Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy [Phase 1]
Summary
A Phase 1 clinical trial is evaluating the safety and tolerability of adding chloroquine to standard anti-tuberculosis therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Tuberculosis Infection | Phase 1 | Status: RECRUITING